MC1879A1 - Derives de la pyridazodiazepine - Google Patents

Derives de la pyridazodiazepine

Info

Publication number
MC1879A1
MC1879A1 MC871934A MC1934A MC1879A1 MC 1879 A1 MC1879 A1 MC 1879A1 MC 871934 A MC871934 A MC 871934A MC 1934 A MC1934 A MC 1934A MC 1879 A1 MC1879 A1 MC 1879A1
Authority
MC
Monaco
Prior art keywords
formula
compound
hydrogen atom
group
acid
Prior art date
Application number
MC871934A
Other languages
English (en)
French (fr)
Inventor
Lawton Geoffrey
Redshaw Sally
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1879A1 publication Critical patent/MC1879A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MC871934A 1986-12-15 1987-12-10 Derives de la pyridazodiazepine MC1879A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868629875A GB8629875D0 (en) 1986-12-15 1986-12-15 Pyridazodiazepine derivatives

Publications (1)

Publication Number Publication Date
MC1879A1 true MC1879A1 (fr) 1989-01-24

Family

ID=10609005

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871934A MC1879A1 (fr) 1986-12-15 1987-12-10 Derives de la pyridazodiazepine

Country Status (17)

Country Link
US (2) US4757069A (da)
EP (1) EP0271795A3 (da)
JP (1) JPS63162693A (da)
KR (1) KR880007538A (da)
AU (1) AU602546B2 (da)
CA (1) CA1291478C (da)
DK (1) DK628087A (da)
FI (1) FI85482C (da)
GB (1) GB8629875D0 (da)
HU (1) HU198492B (da)
IL (1) IL84765A (da)
MC (1) MC1879A1 (da)
NO (1) NO166083C (da)
NZ (1) NZ222825A (da)
PH (1) PH23813A (da)
PT (1) PT86365B (da)
ZA (1) ZA879229B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5308841A (en) * 1990-12-21 1994-05-03 Merrell Dow Pharmaceuticals Inc. Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
DE69220744T2 (de) * 1991-09-27 1997-11-13 Merrell Pharma Inc 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
AU668707B2 (en) * 1992-02-14 1996-05-16 Merrell Pharmaceuticals Inc. Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE
DK0640086T3 (da) * 1992-05-15 1999-12-06 Merrell Pharma Inc Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
US5420271A (en) * 1992-08-24 1995-05-30 Merrell Dow Pharmaceuticals, Inc. 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
DE69329701T2 (de) * 1992-10-30 2001-05-10 Merrell Pharmaceuticals Inc., Cincinnati Mercaptoacetylamid substituiertes bizyclisches laktam zur verwendung als enkephalinase und ace-hemmer
DE69516128T2 (de) * 1994-02-14 2000-12-21 Merrell Pharmaceuticals Inc., Cincinnati Mercaptoacetylamid-1,3,4,5-tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
CN1142831A (zh) * 1994-02-14 1997-02-12 默里尔药物公司 用作脑啡肽酶和ace抑制剂的新的2-取代的1，2-二氢化茚-2-巯基乙酰胺二硫化物衍生物
HUT74584A (en) * 1994-02-14 1997-01-28 Merrell Pharma Inc Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
ATE177098T1 (de) * 1994-02-14 1999-03-15 Merrell Pharma Inc Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
FI963784A0 (fi) * 1994-03-24 1996-09-23 Merrell Pharma Inc Hypokolesteroleemisiä, antiateroskleroottisia ja hypotriglyserideemisiä merkaptoasetyyliamididisulfidijohdannaisia
ATE189392T1 (de) * 1994-03-24 2000-02-15 Merrell Pharma Inc Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
AU2000265534A1 (en) * 2000-02-17 2001-08-27 China Petroleum And Chemical Corporation Multiblock copolymer the preparing method thereof
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use
IE20070935A1 (en) * 2007-12-21 2009-06-24 Trinity College Dublin Guanidine based compounds and their use in the treatment of mental and neurological disorders.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092438A (en) * 1977-04-29 1978-05-30 Carnation Company Non-dairy coffee whitener containing acetate salt
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
GB8320764D0 (en) * 1983-08-02 1983-09-01 Rhodes Joseph Ltd Bending machines
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
EP0187037A3 (en) * 1984-12-21 1988-03-23 Takeda Chemical Industries, Ltd. Piperidine derivatives, their production and use

Also Published As

Publication number Publication date
ZA879229B (en) 1988-06-15
JPS63162693A (ja) 1988-07-06
EP0271795A3 (de) 1989-08-09
PT86365B (pt) 1990-11-20
PH23813A (en) 1989-11-23
NO875200D0 (no) 1987-12-14
HUT47279A (en) 1989-02-28
FI85482B (fi) 1992-01-15
PT86365A (en) 1988-01-01
NZ222825A (en) 1990-11-27
DK628087A (da) 1988-06-16
GB8629875D0 (en) 1987-01-28
NO166083C (no) 1991-05-29
FI85482C (fi) 1992-04-27
EP0271795A2 (de) 1988-06-22
FI875483A0 (fi) 1987-12-14
KR880007538A (ko) 1988-08-27
IL84765A (en) 1991-06-30
DK628087D0 (da) 1987-11-30
HU198492B (en) 1989-10-30
NO166083B (no) 1991-02-18
US4757069A (en) 1988-07-12
FI875483L (fi) 1988-06-16
NO875200L (no) 1988-06-16
CA1291478C (en) 1991-10-29
US4782149A (en) 1988-11-01
AU602546B2 (en) 1990-10-18
IL84765A0 (en) 1988-05-31
AU8225487A (en) 1988-06-16

Similar Documents

Publication Publication Date Title
MC1879A1 (fr) Derives de la pyridazodiazepine
JP6861858B2 (ja) Ｓｓａｏ阻害剤
EP0477049B1 (fr) Dérivés d'amido-3 pyrazole, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
WO1993003013A1 (fr) Derives d'indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant
FR2609716A1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments
CH624932A5 (da)
EP0421861A1 (fr) Dérivés d'hydroxy-2 thiophène et furanne condensés avec un cycle azoté, leur procédé de préparation et leur application en thérapeutique
EP0307303B1 (fr) [(Pyrimidinyl-2)-aminoalkyl]-1 pipéridines, leur préparation et leur application en thérapeutique
MC1639A1 (fr) Derives de la glycerine
EP0370901A1 (fr) Nouveaux dérivés du chromanne actifs sur le système nerveux central, leur procédé de préparation et les compositions pharmaceutiques en contenant
FR2515179A1 (fr) Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
EP0229566B1 (fr) Dérivés de la 1-benzène sulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
EP0823912A1 (fr) Derives d'azacycloalcanes, leur preparation et leurs applications en therapeutique
EP0309324B1 (fr) Procédé de synthèse d'alpha amino N alkyles et de leurs esters. Application à la synthèse de carboxyalkyl dipeptides
MC1334A1 (fr) Derives de triazolopyridazine
EP0835254B1 (fr) Derives d'oxazolidinone, leur preparation et leur application en therapeutique
EP0004494B1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0500443B1 (fr) Nouvelles phényléthanolamino- et phényléthanolaminométhyl-tétralines, procédé pour leur préparation, intermédiaires dans ce procédé et compositions pharmaceutiques les contenant
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
MC1960A1 (fr) Derives d'acide hydrocinnamique
MC1347A1 (fr) Derives de pyridazopyridazine
MC1287A1 (fr) Derives de cyclohexadiene
EP0110484B1 (en) Derivatives of aminopyridinecarboxylic acids, methods for their preparation and pharmaceutical compositions containing them
FI86849C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara azepinonderivat och vid foerfarandet anvaendbara mellanprodukter

Legal Events

Date Code Title Description
YP Annual fee paid